Biblio
TRANSGLUTAMINASE IS REQUIRED FOR EPIDERMAL SQUAMOUS CELL CARCINOMA STEM CELL SURVIVAL. Mol Cancer Res. 2015.
. Transglutaminase 2 binds to the CD44v6 cytoplasmic domain to stimulate CD44v6/ERK1/2 signaling and maintain an aggressive cancer phenotype. Mol Cancer Res. 2023.
. Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid. Cell Death Dis. 2023;14(6):358.
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity. Mol Carcinog. 2021.
. Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors. Eur J Med Chem. 2022;232:114172.
.